This research presents several strengths, notably its investigation into the effects of LDLR 3’ UTR polymorphisms on lipid levels both pre- and post-atorvastatin therapy in a population of adult Chinese Han individuals with dyslipidemia. The gene discussed is LDLR; the disease is metabolic syndrome.